Literature DB >> 16111732

West Nile virus replication interferes with both poly(I:C)-induced interferon gene transcription and response to interferon treatment.

Frank Scholle1, Peter W Mason.   

Abstract

West Nile virus (WNV), the leading cause of viral encephalitis in the United States, is an arthropod-transmitted member of the family Flaviviridae. We have explored the interaction of this positive-strand RNA virus with signaling pathways involved in induction of the host's innate immune response. Phosphorylation of STAT-1 in response to interferon (IFN) treatment and the ability of IFN to establish an antiviral state were reduced in WNV replicon-bearing cell lines. Similarly, the activation of IRF3 and stimulation of IFN-beta transcription in response to the double-stranded RNA (dsRNA) mimetic poly(I:C) were inhibited in replicon-bearing and WNV-infected HeLa cells. In contrast, WNV replicons did not affect IRF3 activation by Sendai virus infection, suggesting that not all IRF3 activating pathways are inhibited by WNV. Taken together, these findings demonstrate that WNV replication in cultured cells interferes with both the response to IFN and synthesis of IFN-beta in response to dsRNA.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16111732     DOI: 10.1016/j.virol.2005.07.021

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  40 in total

Review 1.  Cell-intrinsic innate immune control of West Nile virus infection.

Authors:  Michael S Diamond; Michael Gale
Journal:  Trends Immunol       Date:  2012-06-20       Impact factor: 16.687

2.  Resistance to alpha/beta interferon is a determinant of West Nile virus replication fitness and virulence.

Authors:  Brian C Keller; Brenda L Fredericksen; Melanie A Samuel; Richard E Mock; Peter W Mason; Michael S Diamond; Michael Gale
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

Review 3.  Pathogenesis of West Nile Virus infection: a balance between virulence, innate and adaptive immunity, and viral evasion.

Authors:  Melanie A Samuel; Michael S Diamond
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

4.  A West Nile virus NS4B-P38G mutant strain induces cell intrinsic innate cytokine responses in human monocytic and macrophage cells.

Authors:  Guorui Xie; Huanle Luo; Bing Tian; Brian Mann; Xiaoyong Bao; Jere McBride; Robert Tesh; Alan D Barrett; Tian Wang
Journal:  Vaccine       Date:  2015-01-03       Impact factor: 3.641

Review 5.  Virulence determinants of West Nile virus: how can these be used for vaccine design?

Authors:  Jaclyn A Kaiser; Tian Wang; Alan Dt Barrett
Journal:  Future Virol       Date:  2017-04-28       Impact factor: 1.831

6.  Structure-guided insights on the role of NS1 in flavivirus infection.

Authors:  David L Akey; W Clay Brown; Joyce Jose; Richard J Kuhn; Janet L Smith
Journal:  Bioessays       Date:  2015-03-11       Impact factor: 4.345

7.  West Nile virus nonstructural protein 1 inhibits TLR3 signal transduction.

Authors:  Jason R Wilson; Paola Florez de Sessions; Megan A Leon; Frank Scholle
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

8.  West nile virus: characteristics of an african virus adapting to the third millennium world.

Authors:  Marina Monini; Emiliana Falcone; Luca Busani; Roberto Romi; Franco Maria Ruggeri
Journal:  Open Virol J       Date:  2010-04-22

9.  RNA interference screen for human genes associated with West Nile virus infection.

Authors:  Manoj N Krishnan; Aylwin Ng; Bindu Sukumaran; Felicia D Gilfoy; Pradeep D Uchil; Hameeda Sultana; Abraham L Brass; Rachel Adametz; Melody Tsui; Feng Qian; Ruth R Montgomery; Sima Lev; Peter W Mason; Raymond A Koski; Stephen J Elledge; Ramnik J Xavier; Herve Agaisse; Erol Fikrig
Journal:  Nature       Date:  2008-09-11       Impact factor: 49.962

10.  Virus and host determinants of West Nile virus pathogenesis.

Authors:  Michael S Diamond
Journal:  PLoS Pathog       Date:  2009-06-26       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.